USPTO serial 79284406
VALPHARMA GROUP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 5, 2021
- Examiner
- PODESTA, GIDETTE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with VALPHARMA GROUP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James L. Scott
James L. Scott Warner Norcross + Judd LLP150 Ottawa Ave NW1500 Warner BuildingGrand Rapids, MI 49503Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for skin care; Pharmaceutical preparations for use in urology and dermatology; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Medicinal preparations for the mouth to be applied in the form of capsules and tablets; Veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, dermatological, and immune system related diseases and disorders; Veterinary preparations for the prevention and treatment of bacteria-based diseases or disorders, autoimmune diseases or disorders, and kidney diseases or disorders; Prescription synthetic narcotics and psychotropics; sanitary preparations for medical purposes; Bacteriological preparations for medical purposes; bacteriological preparations for veterinary purposes; dietetic food and substances in the nature of herbal teas, drinks, and bars for medical use; dietetic foods in the nature of a paste adapted for medical or veterinary use; food for babies; herbal preparations for medical purposes; herbal preparations for veterinary purposes; dietary supplements for humans and animals; nutraceuticals for therapeutic purposes in the nature of nutritional supplements; Nutraceuticals for use as a dietary supplement for animals; Nutraceuticals for use as a dietary supplement; Nutraceutical preparations for the treatment of ocular disorders or diseases, bacteria-based diseases or disorders, sleep disorders, autoimmune diseases or disorders, allergies, respiratory disease, kidney diseases or disorders, and diabetes; Nutraceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Probiotic supplements; dietary and nutritional supplements; medicated food supplements; medical plasters; materials for dressings in the nature of gauze for dressing, wadding for dressings | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 5, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 10, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 17, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 16, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 5, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 18, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 30, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 30, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 30, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 10, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 9, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 5, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 5, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 5, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 30, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 18, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 10, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 29, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 29, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 28, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 27, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 20, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 5, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 1, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 30, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |